SML Mahindra acquires Mahindra Truck and Bus Division for ₹525 crore, boosting shares by 20% and enhancing commercial vehicle ...
SML Biopharm Co. Ltd. is harnessing mRNA technology to develop novel immunotherapy-based cancer vaccines, including two candidates for cervical and head and neck cancers caused by human papillomavirus ...
India, July 29 -- The Board of Directors of SML Mahindra Limited has approved the acquisition of Mahindra Truck and Bus ...